<DOC>
	<DOCNO>NCT00620685</DOCNO>
	<brief_summary>The hypothesis study p38 inhibitor ( PH-797804 ) safe well tolerate subject rheumatoid arthritis take methotrexate effect blood level methotrexate .</brief_summary>
	<brief_title>A Study To Evaluate The Safety And Pharmacokinetic Profile Of A P38 Inhibitor ( PH-797804 ) In Subjects With Rheumatoid Arthritis Who Are Also Taking Methotrexate</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Adult RA least 6 month Stable weekly dosage oral methotrexate 12.5 25 mg/week Severe , progressive and/or uncontrolled disease Chronic recent serious infection ; current infection Concomitant use RA therapy methotrexate exception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Arthritis , rheumatoid</keyword>
</DOC>